MutationalPatterns: comprehensive genome-wide analysis of mutational processes
暂无分享,去创建一个
Edwin Cuppen | Francis Blokzijl | Roel Janssen | Ruben van Boxtel | E. Cuppen | R. van Boxtel | Francis Blokzijl | Roel Janssen
[1] Gad Getz,et al. Somatic ERCC2 Mutations Are Associated with a Distinct Genomic Signature in Urothelial Tumors , 2016, Nature Genetics.
[2] M. Stratton,et al. Mutational signatures associated with tobacco smoking in human cancer , 2016, bioRxiv.
[3] Robert Gentleman,et al. Software for Computing and Annotating Genomic Ranges , 2013, PLoS Comput. Biol..
[4] D. Karolchik,et al. The UCSC Genome Browser database: 2016 update , 2015, bioRxiv.
[5] Renaud Gaujoux,et al. A flexible R package for nonnegative matrix factorization , 2010, BMC Bioinformatics.
[6] A. Shilatifard,et al. Precancer Atlas to Drive Precision Prevention Trials. , 2017, Cancer research.
[7] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[8] Martin Renqiang Min,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[9] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[10] Lodewyk F. A. Wessels,et al. Abstract S6-05: High levels of APOBEC3B, a DNA deaminase and an enzymatic source of C-to-T transitions, are a validated marker of poor outcome in estrogen receptor-positive breast cancer , 2013 .
[11] Reuben S Harris,et al. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer , 2016, Science Advances.
[12] M. Stephens,et al. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures , 2015, bioRxiv.
[13] Mauricio O. Carneiro,et al. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.
[14] Andreas Schlicker,et al. Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers , 2014, Hormones and Cancer.
[15] Julian Gehring,et al. SomaticSignatures: inferring mutational signatures from single-nucleotide variants , 2014, bioRxiv.
[16] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[17] S. Nik-Zainal,et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer , 2017, Science.
[18] F. Supek,et al. Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes , 2017, Cell.
[19] Bart De Moor,et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis , 2005, Bioinform..
[20] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[21] Charles L. Lawson,et al. Solving least squares problems , 1976, Classics in applied mathematics.
[22] Peter J. Campbell,et al. C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency , 2014, Genome research.
[23] Chris Sander,et al. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication , 2014, Genome research.
[24] Leland Wilkinson,et al. ggplot2: Elegant Graphics for Data Analysis by WICKHAM, H. , 2011 .
[25] Nam Huh,et al. Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes. , 2014, Cell reports.
[26] P. Campbell,et al. EMu: probabilistic inference of mutational processes and their localization in the cancer genome , 2013, Genome Biology.
[27] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[28] P. Hanawalt,et al. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair , 2016, Cell.
[29] David M. Wilson,et al. DNA repair mechanisms in dividing and non-dividing cells. , 2013, DNA repair.
[30] E. Birney,et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures , 2017, Nature Medicine.
[31] C. Lawson,et al. Solving least squares problems , 1976, Classics in applied mathematics.
[32] Rafael Rosales,et al. signeR: an empirical Bayesian approach to mutational signature discovery , 2017, Bioinform..
[33] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[34] Anushi Shah,et al. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes , 2016, Nature.
[35] Nuria Lopez-Bigas,et al. Nucleotide excision repair is impaired by binding of transcription factors to DNA , 2015 .
[36] J. Hoeijmakers. DNA damage, aging, and cancer. , 2009, The New England journal of medicine.
[37] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[38] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[39] P. Hanawalt,et al. Transcription Domain-Associated Repair in Human Cells , 2006, Molecular and Cellular Biology.
[40] Ben Lehner,et al. Differential DNA mismatch repair underlies mutation rate variation across the human genome , 2015, Nature.
[41] Xavier Castells,et al. MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes , 2016, BMC Bioinformatics.
[42] Michael O Dorschner,et al. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing , 2009, Proceedings of the National Academy of Sciences.